ANNX
Price:
$4.9
Market Cap:
$586.02M
Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmic conditions. Central to its approach is the C1q molecule, which initiates the classical complement pathway. The company targets this pathway to address specific disease mechanisms, such as those seen in antibody-mediated autoimmune disorders and complement-driven neurodegeneration. The company's developmental pipeline features several promising candidates. ANX005, a monoclonal antibody, is in advanced clinical testing, undergoing Phase II/III trials for Guillain-Barré syndrome, as well as Phase...[Read more]
Industry
Biotechnology
IPO Date
2020-07-24
Stock Exchange
NASDAQ
Ticker
ANNX
According to Annexon, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.08. This represents a change of 13.89% compared to the average of -3.58 of the last 4 quarters.
The mean historical PE Ratio of Annexon, Inc. over the last ten years is -9.92. The current -4.08 PE Ratio has changed 4.01% with respect to the historical average. Over the past ten years (40 quarters), ANNX's PE Ratio was at its highest in in the March 2018 quarter at -0.35. The PE Ratio was at its lowest in in the September 2020 quarter at -13.74.
Average
-9.92
Median
-5.08
Minimum
-36.24
Maximum
-1.99
Discovering the peaks and valleys of Annexon, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 98.02%
Maximum Annual PE Ratio = -1.99
Minimum Annual Increase = -69.38%
Minimum Annual PE Ratio = -36.24
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.75 | -26.24% |
| 2024 | -5.08 | 98.02% |
| 2023 | -2.56 | 28.99% |
| 2022 | -1.99 | -42.20% |
| 2021 | -3.44 | -49.15% |
| 2020 | -6.76 | -63.05% |
| 2019 | -18.31 | 64.95% |
| 2018 | -11.10 | -69.38% |
The current PE Ratio of Annexon, Inc. (ANNX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.80
5-year avg
-3.36
10-year avg
-9.92
Annexon, Inc.’s PE Ratio is less than DBV Technologies S.A. (-3.35), less than Larimar Therapeutics, Inc. (-1.73), less than Altimmune, Inc. (-2.90), less than Korro Bio, Inc. (-1.11), less than enGene Holdings Inc. (-1.30), less than LB Pharmaceuticals Inc Common Stock (-1.40), less than Aura Biosciences, Inc. (-3.58), less than Kyverna Therapeutics, Inc. (-2.46), less than AC Immune S.A. (-2.93), greater than DiaMedica Therapeutics Inc. (-8.24),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.35 | $371.50M | |
| -1.73 | $311.50M | |
| -2.90 | $238.29M | |
| -1.11 | $129.29M | |
| -1.30 | $88.06M | |
| -1.40 | $860.30M | |
| -3.58 | $407.03M | |
| -2.46 | $353.40M | |
| -2.93 | $244.26M | |
| -8.24 | $315.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexon, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Annexon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Annexon, Inc.'s PE Ratio?
How is the PE Ratio calculated for Annexon, Inc. (ANNX)?
What is the highest PE Ratio for Annexon, Inc. (ANNX)?
What is the 3-year average PE Ratio for Annexon, Inc. (ANNX)?
What is the 5-year average PE Ratio for Annexon, Inc. (ANNX)?
How does the current PE Ratio for Annexon, Inc. (ANNX) compare to its historical average?